This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsPromentis PharmaceuticalsPromentis Pharmaceuticals Funding Rounds, Valuation & Investors
Promentis Pharmaceuticals Funding
$0
33 rounds
Promentis Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on January 17, 2014.
Investors of Promentis Pharmaceuticals
Founder, RTMS, Inc., now a unit of Fidelity Financial; Founder, Golden Angels Network; EdTech Investor (LP in OWL VC); Director, First Business (FBIZ:Nasdaq)
National Institutes of Health
OrbiMed
F-Prime
Golden Triangle Angel Network
Aisling Capital
Golden Angels Investors
Rounds
B